Maravai LifeSciences Holdings

MRVI · NASDAQ

$7.20+$0.21 (+3.00%)TodayMarket closed · Oct 20, 7:50 PM ET

Prev close $6.99

About MRVI

Maravai Lifesciences Holdings, Inc. engages in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The company is headquartered in San Diego, California and currently employs 435 full-time employees. The company went IPO on 2020-11-20. Its segments include TriLink and Cygnus. Its TriLink segment provides nucleic acid products and related services, including messenger ribonucleic acid (mRNA), oligonucleotides, CleanCap mRNA capping technology, ModTail poly(A) tail modification technology, synthesis inputs, nucleoside triphosphates, enzymes, and mRNA manufacturing services. Its Cygnus segment provides biologics safety testing products and services, including host cell protein enzyme-linked immunosorbent assay (ELISA) kits, impurity detection assays, viral clearance prediction tools, ancillary reagents, and custom analytical services. Its TriLink and Cygnus segments produce materials used in research and biopharmaceutical production, clinical trial vaccines and vaccine support products.

Employees: 435
Headquarters: San Diego, California
Listed: Nov 20, 2020
Sector: Health Care
Industry: Life Sciences Tools & Services
Website: maravai.com

Leadership

Maravai LifeSciences Holdings executives
Name	Title	Since	Age
Robert Eckert	—	—	63
Bernd Brust	—	2025	58
Rajesh Asarpota	—	—	58
Kurt Oreshack	—	—	45
Christine Dolan	—	—	57
Sean Cunningham	—	—	49
Luke Marker	—	—	40
Constantine Mihas	—	—	58
John Deford	—	—	63
Susannah Gray	—	—	64
Gregory Lucier	—	—	61

Revenue by product and region

Fiscal year ended Dec 31, 2025: $185.74M total revenue

By product

TriLink$119.79M64.5%
Cygnus$65.96M35.5%

By region

North America$112.38M60.5%
Asia Pacific$41.47M22.3%
Europe, the Middle East and Africa$30.92M16.6%
Latin and Central America$971.00K0.5%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Maravai LifeSciences Holdings suppliers and customers
Company	Relationship	Country	Correlation
BioNTech ADR BNTX	Customer	DE	0.82
CureVac CVAC	Customer	DE	0.80
Shanghai Fosun Pharm H	Customer	CN	0.70
Perella Weinberg A PWP	Supplier	US	0.60
Daiichi Sankyo	Customer	JP	-0.42
Pfizer PFE	Customer	US	-0.48
AmberGen, Inc.	Supplier	US	—
Broad Institute, Inc.	Supplier and customer	US	—
GREENLIGHT BIOSCIENCES INC	Customer	US	—
Louisiana State University	Supplier and customer	US	—

Similar companies

Companies in the same industry as Maravai LifeSciences Holdings

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.